Announcements Trials

Browse Landscape

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasm Invasiveness 1 Disease 1

Interventions

Paclitaxel 35 Carboplatin 35 Bevacizumab 14 olaparib 13 niraparib 11 apatinib 11 Gemcitabine 10 liposomal doxorubicin 9 Hyperthermic Intraperitoneal Chemotherapy 9 Cisplatin 9 pembrolizumab 8 Cyclophosphamide 8 fludarabine 7 Etoposide 7 Topotecan 6 fluzoparib 5 Surveys and Questionnaires 5 Drug Therapy 5 Albumin-Bound Paclitaxel 5 anlotinib 4 Immunohistochemistry 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Cytoreduction Surgical Procedures 4 Taxes 3 Surgical Procedures, Operative 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Neoadjuvant Therapy 3 Laparoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × CA-125 Antigen × Clear all

NCT02296307 2024-05-02

DOvEE

McGill University

13,600 enrolled

Disease, Neoplasm Invasiveness, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡